Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1824-7288
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy ; volume:35 ; number:1 ; day:20 ; month:11 ; year:2009 ; pages:1-8 ; date:12.2009
The Italian journal of pediatrics ; 35, Heft 1 (20.11.2009), 1-8, 12.2009
- Urheber
-
Distefano, Giuseppe
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1824-7288-35-37
- URN
-
urn:nbn:de:1111-2016032339016
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Distefano, Giuseppe
- SpringerLink (Online service)
Ähnliche Objekte (12)
Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
Electrocardiograms for cardiomyopathy risk stratification in children with anthracycline exposure
Anthracycline-induced cardiotoxicity and renin-angiotensin-aldosterone system—from molecular mechanisms to therapeutic applications
Therapeutic potential of finerenone for diabetic cardiomyopathy: focus on the mechanisms
Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives
Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysis
Mitochondrial mechanisms in septic cardiomyopathy
Selective autophagy in cancer: mechanisms, therapeutic implications, and future perspectives
Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy
Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets
Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy
Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
Electrocardiograms for cardiomyopathy risk stratification in children with anthracycline exposure
Anthracycline-induced cardiotoxicity and renin-angiotensin-aldosterone system—from molecular mechanisms to therapeutic applications
Therapeutic potential of finerenone for diabetic cardiomyopathy: focus on the mechanisms
Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives
Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysis
Mitochondrial mechanisms in septic cardiomyopathy
Selective autophagy in cancer: mechanisms, therapeutic implications, and future perspectives
Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy
Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets
Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy
Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
Electrocardiograms for cardiomyopathy risk stratification in children with anthracycline exposure
Anthracycline-induced cardiotoxicity and renin-angiotensin-aldosterone system—from molecular mechanisms to therapeutic applications
Therapeutic potential of finerenone for diabetic cardiomyopathy: focus on the mechanisms
Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives
Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysis
Mitochondrial mechanisms in septic cardiomyopathy
Selective autophagy in cancer: mechanisms, therapeutic implications, and future perspectives
Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy
Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets